Plazza has closed a $15 million Series A led by Accel, Elevation Capital and Nexus Venture Partners.
The company plans to expand from two Bengaluru stores to around 20 by December.
Its strategic bet is that local prescription data can improve medicine availability without sacrificing delivery speed.
The central risk is whether deep inventory produces healthy turns or creates working-capital and expiry pressure.
Mature-store contribution margins and complete-prescription rates will matter more than the number of outlets opened.
Read the full story on StartupFox